Clinical trial
Neural Correlates In Mild Alzheimer's Disease
NCT00477659 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00477659 |
|---|---|
| Title | Neural Correlates In Mild Alzheimer's Disease |
| Official title | A Single Center Study To Examine Neural Correlates Of Cognition In Subjects With Mild Alzheimer's Disease After Three Months Of Open Label Donepezil HCl (Aricept® ) Treatment |
| Lead sponsor | Eisai Inc., Industry |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | Donepezil hydrochloride |
| Enrollment | 14 |
| Start date | Jul 23, 2007 |
| Primary completion | Aug 15, 2008 |
| Completion | Aug 15, 2008 |
| First posted | May 24, 2007 |
| Last update posted | Nov 10, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: